# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Behcet's disease

Behcet disease
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 81 results.
Inactivity Behavior and Exercise Bariers in Patients With Behçet Disease
Status: Recruiting
Last Changed: Feb 15, 2019
First Received: Feb 12, 2019
Disease(s): Behçet Disease
Intervention(s): Study group
Locations: Gazi University, Ankara, Turkey
Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
Status: Not yet recruiting
Last Changed: Sep 10, 2020
First Received: Aug 27, 2020
Disease(s): Behçet Disease
Intervention(s): Apremilast, Placebo
A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease
Status: Completed
Last Changed: Oct 17, 2019
First Received: Jul 22, 2015
Disease(s): Behcet Disease
Intervention(s): Infliximab
Locations: Busan, Korea, Republic of
Daegu, Korea, Republic of
Gangwon-do, Korea, Republic of
Gyeonggi-do, Korea, Republic of
Seoul, Korea, Republic of
... and 1 other locations.
Role of Regulatory B Cells in Behçet's Disease
Status: Completed
Last Changed: May 06, 2020
First Received: May 06, 2020
Disease(s): Behcet Disease
Intervention(s): Flow-cytometric assay, 2D Echocardiographic analysis, Two-Dimensional speckle tracking echocardiography
Locations: Assiut University, Assiut, Egypt
Behçet's Disease and Eosinophil Cationic Protein
Status: Completed
Last Changed: Apr 26, 2012
First Received: Apr 25, 2012
Disease(s): Behçet's Disease
Intervention(s): eosinophil cationic protein
Locations: Cukurova University, Faculty of Medicine, Rheumatology-Immunology Department, Adana, Turkey
Low-dose IL-2 Treatment on Behcet's Disease
Status: Recruiting
Last Changed: Jan 18, 2020
First Received: Aug 22, 2019
Disease(s): Behcet's Disease
Intervention(s): Low-dose IL-2
Locations: Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China
1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement
Status: Completed
Last Changed: Jun 11, 2020
First Received: Apr 29, 2016
Disease(s): Behcet Disease
Intervention(s): Canakinumab
Locations: Novartis Investigative Site, Istanbul, Turkey
Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)
Status: Completed
Last Changed: Mar 22, 2019
First Received: Oct 11, 2013
Disease(s): Behcet's Disease
Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .
Status: Not yet recruiting
Last Changed: Mar 27, 2020
First Received: Sep 26, 2019
Disease(s): Behçet Disease
Anti IL-18 (GSK1070806) in Behcet's Disease
Status: Unknown status
Last Changed: May 11, 2018
First Received: May 11, 2018
Disease(s): Behcet's Disease
Intervention(s): GSK1070806
Locations: Addenbrooke's Hospital, University of Cambridge NHS Foundation Trust, Cambridge, United Kingdom